Community-Acquired Pneumonia and Sepsis Caused by a Multiresistant Staphylococcus Aureus Strain Resulting in a Severe and Long-Lasting Multiple Organ Inflammatory Involvement

An exceptional case report of community-acquired, disseminated infection caused by a methicillin-resistant Staphylococcus aureus strain, responsible for pneumonia, sepsis, and scattered septic embolism, and accompanied by diffuse polyvisceritis and thrombophlebitis as signs of an overwhelming extensive activation of the immune system, is reported and discussed on the grounds of the most recent evidence in literature. The striking features of a severe, multiresistant S. aureus polyvisceral disease associated with multiple immune-mediated focal manifestations are in contrast with the community-acquired origin of infection and the apparent absence of supporting factors for both antimicrobial resistance and the unexpected, exaggerated immune activation occurred in an otherwise healthy man. The extensive immune activation status (as demonstrated by a proportionally maintained absolute lymphocyte cont and a T-cell subset study pointing out an increased quote of CD4+, CD34+, and CD4-CD8- cells, compared with a proportional decrease of CD8+ T-lymphocytes) probably had a prominent role in prompting several focal clinical features of our patient, which apparently were not directly related to bacterial invasion, such as the polyvisceritis, the massive pleuric and pericardial effusion, the myocarditis-pericarditis, and the thrombophlebitis occurring in multiple and remote body sites, as compared with to the initial respiratory localization. This case report raises multiple questions regarding the epidemiology, pathogenesis, clinical manifestations, and management of complicated S. aureus infection, including the role of novel antimicrobial agents and corticosteroids.

[1]  R. Manfredi A re-emerging class of antimicrobial agents: streptogramins (quinupristin/dalfopristin) in the management of multiresistant gram-positive nosocomial cocci in hospital setting. , 2005, Mini reviews in medicinal chemistry.

[2]  B. Lambrecht,et al.  Proinflammatory Bacterial Peptidoglycan as a Cofactor for the Development of Central Nervous System Autoimmune Disease , 2005, The Journal of Immunology.

[3]  R. Manfredi,et al.  Severe staphylococcal knee arthritis responding favourably to linezolid, after glycopeptide-rifampicin failure: A case report and literature review , 2005, Scandinavian journal of infectious diseases.

[4]  T. Yao,et al.  Staphylococcal endocarditis and multiple emboli in a patient with systemic lupus erythematosus. , 2004, The Journal of rheumatology.

[5]  Judith R. Campbell,et al.  Features of Invasive Staphylococcal Disease in Neonates , 2004, Pediatrics.

[6]  A. Koyama,et al.  Staphylococcus aureus antigens induce IgA-type glomerulonephritis in Balb/c mice. , 2004, Journal of nephrology.

[7]  M. Nagata,et al.  Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. , 2004, Kidney international.

[8]  A. Goldstein,et al.  Delayed disseminated Staphylococcus aureus infection following chickenpox , 2004, Journal of paediatrics and child health.

[9]  J. P. Calvo,et al.  Mielopatía transversa aguda asociada a S. aureus: la dificultad del diagnóstico diferencial , 2004 .

[10]  A. Azzará,et al.  Expansion of TcRαβ+CD3+CD4–CD8– (CD4/CD8 Double-Negative) T Lymphocytes in a Case of Staphylococcal Toxic Shock Syndrome , 2004, Acta Haematologica.

[11]  J. P. Pérez Calvo,et al.  [Acute transverse myelopathy associated to S. aureus: a difficult differential diagnosis]. , 2004, Neurologia.

[12]  P. Serra,et al.  Successful treatment of disseminated cerebritis complicating methicillin-resistant Staphylococcus aureus Endocarditis unresponsive to vancomycin therapy with linezolid. , 2004, Scandinavian journal of infectious diseases.

[13]  S. Stefani,et al.  Epidemiology of methicillin-resistant staphylococci in Europe. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  V. D’Agati,et al.  IgA-dominant acute poststaphylococcal glomerulonephritis complicating diabetic nephropathy. , 2003, Human pathology.

[15]  W. Gransden,et al.  Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  T. Proft,et al.  Bacterial superantigens , 2003, Clinical and experimental immunology.

[17]  H. Hashimoto,et al.  Systemic lupus erythematosus-like autoimmune abnormalities induced by bacterial infection. , 2003, Clinical and experimental rheumatology.

[18]  P. Courvalin,et al.  Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey. , 2003, The Journal of antimicrobial chemotherapy.

[19]  A. Gasbarrini,et al.  Onset of Berger disease after Staphylococcus aureus infection: septic arthritis after anterior cruciate ligament reconstruction. , 2003, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[20]  M. Hamidou,et al.  [Superantigens and vasculitis]. , 2003, Annales de medecine interne.

[21]  M. Amagai Desmoglein as a target in autoimmunity and infection. , 2003, Journal of the American Academy of Dermatology.

[22]  J. Turnidge Impact of Antibiotic Resistance on the Treatment of Sepsis , 2003, Scandinavian journal of infectious diseases.

[23]  J. Williamson,et al.  Disseminated oxacillin-resistant Staphylococcus aureus infection responsive to vancomycin and quinupristin-dalfopristin combination therapy. , 2003, The Journal of antimicrobial chemotherapy.

[24]  L. Calza,et al.  A Prospective Surveillance Study of Methicillin Resistance Levels of Staphylococcus aureus Strains Isolated in Selected High-Risk Wards of a Large Tertiary Care Hospital , 2002 .

[25]  B. Berger-Bächi,et al.  Factors influencing methicillin resistance in staphylococci , 2002, Archives of Microbiology.

[26]  C. Jacob,et al.  In vivo staphylococcal superantigen-driven polyclonal Ig responses in mice: dependence upon CD4(+) cells and human MHC class II. , 2001, International immunology.

[27]  D. Floret Aspects cliniques des syndromes toxiniques streptococciques et staphylococciques , 2001 .

[28]  D. Floret [Clinical aspects of streptococcal and staphylococcal toxinic diseases]. , 2001, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[29]  H. Morita,et al.  Reversible Nephrotic Syndrome in a Patient with Amyloid A Amyloidosis of the Kidney following Methicillin-Resistant Staphylococcus aureus Infection , 2001, Nephron.

[30]  C. Dodt,et al.  [Toxic shock syndrome with multi-organ involvement]. , 2000, Deutsche medizinische Wochenschrift.

[31]  T. Krakauer,et al.  Immune response to staphylococcal superantigens , 1999, Immunologic research.